Recent advances in vaccine and immunotherapy for COVID-19

Ali A. Rabaan, Shamsah H. Al-Ahmed, Ranjit Sah, Jaffar A. Al-Tawfiq, Ayman M. Al-Qaaneh, Lamiaa H. Al-Jamea, Alexander Woodman, Manaf Al-Qahtani, Shafiul Haque, Harapan Harapan, D. Katterine Bonilla-Aldana, Pavan Kumar, Kuldeep Dhama, Alfonso J. Rodriguez-Morales

Producción científica: Artículo CientíficoArtículo originalrevisión exhaustiva

28 Citas (Scopus)


The COVID-19 pandemic caused by SARS-CoV-2 has resulted in millions of cases and hundreds of thousands of deaths. Beyond there being no available antiviral therapy, stimulating protective immunity by vaccines is the best option for managing future infections. Development of a vaccine for a novel virus is a challenging effort that may take several years to accomplish. This mini-review summarizes the immunopathological responses to SARS-CoV-2 infection and discusses advances in the development of vaccines and immunotherapeutics for COVID-19.

Idioma originalInglés estadounidense
Páginas (desde-hasta)3011-3022
PublicaciónHuman Vaccines and Immunotherapeutics
EstadoIndizado - 2020
Publicado de forma externa

Nota bibliográfica

Publisher Copyright:
© 2020 The Author(s). Published with license by Taylor & Francis Group, LLC.


Profundice en los temas de investigación de 'Recent advances in vaccine and immunotherapy for COVID-19'. En conjunto forman una huella única.

Citar esto